ENTtoday

Articles tagged with "head and neck cancer"

Lecturer Warns Against Overuse of CRT: Says many early-stage laryngeal cancer patients overtreated

Chemoradiation therapy (CRT) for head and neck cancer is overused at some centers in patients with early-stage laryngeal cancer, and more care should be taken not to overtreat patients with therapy that can have toxic effects, said invited lecturer Jonas Johnson, MD, at the Annual Meeting of the Triological Society, held here on April 29 as part of the Combined Otolaryngology Spring Meetings.

New Tool Could Aid Decisions on Elective Neck Dissection: Fast polymerase chain reaction detects sentinel lymph node positivity

Quantitative real-time polymerase chain reaction (Q-PCR) can be a valuable tool in the operating room to determine whether head and neck cancer patients should go on to elective neck dissection, researchers said here on April 29 at the Annual Meeting of the Triological Society, held as part of the Combined Otolaryngology Spring Meetings.

Pretreatment Swallowing Assessment in Head and Neck Cancer Patients

What are the patient variables associated with swallowing dysfunction in head and neck cancer (HNCa) patients prior to intervention? Background: Recent studies have shown that pretreatment deficits are common in HNCa patients, particularly those with advanced stage disease. Further, the research has shown poor correlation between measurable deficits and patients’ perceptions of these deficits. Determining aspiration […]

Cost Analysis of Transoral Surgery versus XRT for Early-Stage Glottic Cancer

Which treatment for Tis/T1 glottic carcinoma among adult patients, transoral CO2 laser excision (TOL) or external beam radiation (XRT), is superior in terms of cost utility? Background: Cancer of the larynx is the most common head and neck cancer, with 75 percent of cases confined to the level of the glottis. The goal of treatment for […]

Facility and Case Volume Tied to Cancer Death Rates

Patients with cancer of the larynx who are treated at teaching and research hospitals that see high volumes of such patients are the least likely to die within a year of their diagnoses, researchers said at the annual meeting of the American Head and Neck Society.

Shifting Paradigms in Thyroid Cancer Follow-Up

What needs to be in the follow-up of certain patients who have undergone treatment for thyroid cancer? Uncertainties still exist, but change is in the air. The 2009 American Thyroid Association (ATA) guidelines promise to clarify at least some issues that affect practice.